RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITEDSET: RAM🇹🇭 TH

Business Operation · 2025

Corporate Information

Company Name

RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED

Telephone

1512 , 02-7439999

Website

www.ram-hosp.co.th

Email

callcenter@ram-hosp.com

Dividend Policy

Dividend Policy

Not less than 20% of net profit (base on the separated financial statements) after deducting corporate income tax and legal reserve

Historical Dividend Payments

This YearLast Year2 Years Ago3 Years Ago4 Years AgoMetricDescription
1.090.981.221.813.48Net profit per share (Baht : Share)Net profit per share (baht : share)
0.10.40.90.90.72Dividend per share (Baht : Share)Dividend per share (baht : share)
1,2001,2001,2001,2001,200Dividend stock ratio (Number of original shares: dividend shares)Ratio of stock dividend payment (existing share : stock dividend)
00000Dividend share value per share (Baht : Share)Value of stock dividend per share (baht : share)
00000Total dividend payment value (Baht : Share)Total dividend payment (baht : share)
9417449.7220.69Dividend payout ratio to net profit (%)Dividend payout ratio compared to net profit (%)

Major Shareholders

Introduction

The top 10 largest shareholders as of December 30, 2025, are as follows:

Major Shareholders

No.NameShares% SharesParent No.
21,100F&S 79 COMPANY LIMITED293,548,97524.46
21,101CYPRESS CONSOLIDATED HEALTHCARE PTE.LTD. .299,880,00024.99
21,103VIBHAVADI MEDICAL CENTER PUBLIC PUBLIC COMPANY LIMITED75,568,7006.3
21,104SYNPHAET COMPANY LIMITED34,706,2002.89
21,105MR. SIRIPONG LUENGVARINKUL28,508,2002.38
21,106MISS RUKKAGEE KANJANAPITAK52,206,2004.35
21,107MR. PITCHAYA SOMBURANASIN22,416,1001.87
21,109MRS. ANCHANA SIRIVONGS13,166,4001.1
21,110Dr. Chamnan Chanapai, DDS12,749,9001.06
21,116Dr. Bolvadee Kanjanapitak300,0000.0221,106
21,117Mrs. Jinnapa Chanapai2,650,9000.2221,110
21,118DR. RACHA SOMBURANASIN1,500,0000.1221,107
21,119MS. WILAIPHAN SOMBURANASIN4,992,6000.4221,107
31,897 Mr. Ruchit Kanjanapitak21,246,0001.7721,106
31,902Mr. Talit Chuen-Im22,665,0001.89
31,904MISS Tassawan Sirvongs10,300,0000.8621,109
31,905MR. Sati Siivongs10,000,0000.8321,109
31,936MISS Daraproud Chanapai10,000,0000.8321,110
31,937MR. DHITI CHANAPAI12,250,0001.0221,110

Remark

1) CYPRESS CONSOLIDATED HEALTHCARE PTE.LTD. acquired 59,880,000 shares of RAM, representing 4.99 percent of RAM's total issued and paid-up shares, from Chiangmai Ram Hospital Company Limited on September 29, 2025. 2) CYPRESS CONSOLIDATED HEALTHCARE PTE.LTD. has two representatives on the Company's Board of Directors, who are non-executive directors and do not have signing authority on behalf of the Company. 3) F&S 79 Company Limited has one representative on the Company's Board of Directors, who is a non-executive director and does not have signing authority on behalf of the Company.

Business Strategies Overview

Chairman's Message

Dear Shareholders, Service Recipients, and Partners,

Throughout its 38 years of operation, Ramkhamhaeng Hospital Public Company Limited has remained committed to delivering healthcare services with warmth and professional expertise. The Company continues to uphold high medical standards through a team of specialized physicians in order to meet the diverse healthcare needs of the public.

In 2025, the Company continued to focus on responding to the evolving landscape of the healthcare system, rapid advancements in medical technology, and the growing demand for more personalized medical services. The Group has consistently invested in modern and internationally standardized medical technologies to enhance the accuracy, safety, and effectiveness of treatments.

Notable medical innovations include intraoperative detection of parathyroid tissue, which helps preserve parathyroid glands responsible for hormone production during thyroid surgery. The introduction of Endoscopic Ultrasound (EUS) allows physicians to examine deep structural abnormalities within the gastrointestinal tract while performing endoscopy, enabling precise localization for tissue biopsy procedures.

In surgical treatment, microincision surgery has become a widely accepted standard. Ramkhamhaeng Hospital provides minimally invasive surgical services across multiple specialties, including surgery, obstetrics and gynecology, orthopedics, ear–nose–throat (ENT), and cardiovascular surgery. This approach enhances surgical precision while reducing pain, minimizing incision size, and allowing faster patient recovery compared with conventional surgery.

The Ramkhamhaeng Hospital Heart Center provides comprehensive services for cardiovascular diseases, including diagnosis, treatment, surgery, and catheter-based interventions. In 2025, the Center introduced Pulsed Field Ablation (PFA) technology for the treatment of cardiac arrhythmias, which offers higher precision and safety in eliminating abnormal electrical signals in the heart.

In response to the growing prevalence of osteoporosis and sarcopenia, particularly among the elderly and individuals with limited physical activity, the Company has introduced advanced diagnostic technologies, including DEXA Scan and Bioelectrical Impedance Analysis (BIA), to support screening and diagnosis of bone density loss and muscle mass reduction.

In cancer care, the Radiation Therapy Center at Ramkhamhaeng 2 Hospital utilizes advanced 4D radiation therapy technology, which synchronizes radiation delivery with the patient’s breathing motion. This technology improves treatment accuracy, reduces the impact on surrounding healthy tissues, and enhances safety and treatment outcomes.

The Group has also expanded cancer treatment capabilities in regional areas through the Radiation Therapy Center at Chiang Rai Ram Hospital. Meanwhile, the Vibharam Hospital Group has strengthened its medical laboratory services and Nuclear Medicine capabilities to enhance diagnostic potential across affiliated hospitals.

In addition, Vibharam Hospital Group places emphasis on providing healthcare services for insured persons under the Social Security Scheme, allowing patients to combine social security benefits with private health insurance coverage. This approach helps reduce treatment costs while expanding healthcare access for patients.

The Company also recognizes the importance of strengthening the foundation of medical education and continuously developing human resources to support future changes in medical technologies and treatment models. Key initiatives include promoting knowledge in genomic medicine, such as genetic sequencing using Next-Generation Sequencing (NGS) technology, which supports the development of personalized cancer treatment and targeted therapy. Training programs have also been conducted in collaboration with international experts from Mayo Clinic, USA, particularly in the field of cardiopulmonary rehabilitation and the use of Cardiopulmonary Exercise Testing (CPET). In addition, the Company promotes knowledge management and multidisciplinary treatment approaches to enhance comprehensive patient care.

In driving the organization through digital innovation, the Company continues its Digital Transformation toward becoming a Smart Hospital. This includes the development of integrated patient information management systems and the RAM Health Mart application, which facilitates patient access to treatment information and healthcare services. The Company has also developed new systems that enable effective data connectivity among affiliated hospitals and is preparing to integrate Artificial Intelligence (AI) technologies to support patient data management, improving accuracy, safety, and operational efficiency.

Beyond continuously improving medical services, the Company also places great importance on enhancing patient experience and comfort. Various facility improvements have been undertaken, including the expansion of service areas in new buildings, renovation of patient rooms to provide modern and comfortable environments, and upgrades to examination rooms and supporting facilities such as waiting areas, restaurants, convenience stores, and valet parking services for the convenience of all visitors.

The Board of Directors remains committed to overseeing the Company’s operations in alignment with its strategic goals, strengthening the organization’s capabilities and readiness to meet the healthcare needs of people across all regions, while supporting the Company’s stable and sustainable growth.

On behalf of the Board of Directors, I would like to express my sincere appreciation to all shareholders, service recipients, and partners for your continued trust and support. I would also like to thank our doctors, nurses, and all personnel whose dedication is the key driving force behind Ramkhamhaeng Hospital’s continued growth. The Company will continue to uphold good corporate governance while advancing medical technology and standards to create sustainable value for Thai society.

Dr. Pitchaya Somburanasin, M.D.

Chairman of the Group Executive Committee

Ramkhamhaeng Hospital Public Company Limitedd

Vision

Aiming to be Thailand’s leading health network, delivering international medical standards accessible to everyone , growing sustainably alongside Thai society.

Objectives

To connect and manage an integrated health network to deliver international-standard healthcare, through the integration of expertise, innovation, and long-term health partnerships.

Goals

-

Business Strategies

  1. Focus on Clinical ExcellenceAttract and retain best-in-class talent to deliver strong patient outcomes. Invest in technology and digital.

  2. Flagship hospitals driven growthCapacity expansion (RAM 2, THG 2), optimize procedure-mix and ALOS;
    New COEs. Optimize support function.

  3. Commitment to ESG and sustainabilityCorporate governance, social responsibility and risk management.

  4. Optimize Existing AssetsImprove occupancy; cross-referral, Rebalance case mix; right-size cost structure; Divest non-core assets.

  5. Prudent Capital ManagementFocus on cash flow, reduce leverage and prioritize high ROCE projects; streamline and rationalize investments.

  6. Expand Hospital Network
    Brownfield expansion, mergers & acquisitions and partnerships

Material Changes & Developments

Material Changes & Developments

YearDescription
2,025
  • Ramkhamhaeng Hospital Group (RAM) implemented a rebranding strategy to elevate the image from a hospital that focuses on the elderly to a hospital network that covers all ages, with a focus on preventive health services and holistic healthcare. To expand the user base of the new generation and foreigners, along with adjusting the investment strategy to focus on mergers and acquisitions. (M&A) and brownfield investments to support rapid growth. It is in line with the changes in social structure and consumer behavior in the modern era.

  • On June 10, 2025, the Extraordinary General Meeting of Shareholders approved the additional investment in ordinary shares of Thonburi Healthcare Group Public Company Limited (THG) through a private placement to the Company in the amount of 430,500,000 shares with a par value of Baht 1.00 per share at an offering price of Baht 8.65 per share, totaling Baht 3,723,825,000. Shares accounted for 49.99% of the total issued and outstanding shares.

  • On September 26, 2025, the Board of Directors approved the acquisition of 2,848,000 additional shares of Chiang Mai Ram Hospital Co., Ltd. (CMH), representing 7.12% of the total issued and outstanding shares, from Chiang Mai Ram Medical Business Public Company Limited (CMR), a connected person of the Company, with an investment value of 427,200,000 baht. After the completion of the transaction, the Company will hold 50.01% of the total issued and outstanding shares in CMH.

  • On October 17, 2025, Dr. Rukkajee Kanchanapithak Group Chief Executive Officer Ramkhamhaeng Hospital and its affiliates received the award and plaque of honor "Business Role Model 2025 in the Medical Sector" from the Science and Technology Council of Thailand (NST) Foundation.

  • On November 22, 2025, Ramkhamhaeng Hospital Public Company Limited ("the Company" or "RAM") changed the shareholding structure of the Company's shareholders. The operation is carried out in full accordance with the rules and requirements of the relevant regulatory agencies.

2,024
  • The Company purchased an additional investment in Thonburi Healthcare Group Public Company Limited with a shareholding ratio of 24.59% after the transaction.

  • The Company changed its management structure. Positions of Executives and Group Executive Committees of the Company.

  • Ramkhamhaeng Hospital received the "Creativity and Innovation Silver Award" at the Muang Thai Life Assurance Hospital Awards.

2,023
  • On January 10, 2023, the Company resolved to dispose of 2,068,800 shares of investment in a subsidiary of Vibharam Hospital (Mahesak Hospital Co., Ltd.) at Baht 275 each. Total value 568,920,000 Baht

  • On March 2, 2023, the Company resolved to invest in the Ratchathani - Romklao Hospital project, a 150-bed hospital located on Romklao Road, Bangkok, with an investment proportion of 7.00%.

  • On March 2, 2023, the Company resolved to purchase new shares of Chiang Mai Ram Medical Business Public Company Limited (CMR), representing 1.18% of CMR's paid-up capital .

  • On March 13, 2023, the Company resolved to invest in MI Calibration System Co., Ltd. 4,999,999 shares of 100 baht each. Total value 499,999,900 Baht

  • On March 21, 2023, the Company resolved to invest in the Mahasarakham Ram Hospital Project, a 120-bed hospital located in Mahasarakham District, Mahasarakham Province, with an investment proportion of 50.00%. -

  • On April 3, 2023, the Company resolved to purchase the new shares of Ramnakara Co., Ltd., making the shareholding ratio after the purchase of the new shares equal to 52.17% of the paid-up registered capital of Ramnakara Co., Ltd.

  • On June 28, 2023 , the Company resolved to purchase the new shares of Chaiyaphum Ram Hospital Co., Ltd., making the shareholding ratio after the purchase of the new shares equal to 78.34% of the Company's paid-up capital. Chaiyaphum Ram Hospital Co., Ltd.

  • On July 14, 2023 The Company changed its management structure. Positions of Executives and Executive Committee of the Company

  • On August 18, 2023, the Company approved The purchase of new shares of Watcharasiriwet Co., Ltd., maintaining the same proportion of 40.26% of the paid-up registered capital. And Approved the cancellation of investment in the Ramkhamhaeng Hospital project 3 and is in the process of finding new investors.

  • On November 22, 2023 , the Company approved change the management structure Positions of Executives and Group Executive Committees of the Company and The Board of Directors of Ramnakara Co., Ltd. resolved to purchase the new shares of Ramnakara Co., Ltd., making the shareholding ratio after the purchase of the new shares equal to 59.73% of the paid-up registered capital of Ramnakara Co., Ltd.

  • On December 15, 2023, the Company resolved to waive the right to purchase the newly issued ordinary shares of Thonburi Hospital Rangsit Co., Ltd., resulting in the proportion of shareholding after the waiver of the right to purchase additional shares equal to 25.00% of the paid-up capital of Thonburi Hospital Rangsit Co., Ltd.

  • Ramkhamhaeng Hospital has been accredited according to AACI "American Accreditation Commission International" from the United States. Safety standards for service users

Use of Proceeds from Securities Offerings

Is There Money Raised from a Securities Offering Still to Report On?

No

Commitments Made in the Registration Statement

Are There Commitments or Conditions from an Offering or Listing?

No

Group Operating-Structure Policy

Description

The Company has a policy to invest in subsidiaries and associates within the private hospital business, considering that such companies are likely to achieve favorable performance in the future.

with the expectation of returns in the form of dividends. The Company tends to invest in available-for-sale securities that offer an average dividend yield exceeding the market interest rate.

Companies Where the Company Holds ≥10%

Companies (≥10% Holding)

Company NameAddressProvinceZip CodeTelephoneFaxBusiness TypeSecurity TypeSharesPaid-up Shares
Chaiyaphum-Ram Hospital Company Limited290/42 Chaiyaphum-Sikhio Road, Nai Mueang Subdistrict, Mueang District, Chaiyaphum Province 36000Chaiyaphum36000--Private HospitalCommon shares4,606,5105,880,000
Mueang Loei Ram Hospital Company Limited546 Moo 1 Maliwan Road, Na An Subdistrict, Mueang District, Loei Province 42000Loei42000-Private HospitalCommon shares32,213,40041,473,500
Vientiane-Ram International Hospital Company LimitedVientiane, Laos-Private Hospital Under ConstructionCommon shares1,750,0007,150,000
Nan Ram Hospital Company Limited553 Moo 4, Chaiyathan Sub-district, Mueang Nan District, Nan ProvinceNan-Private Hospital is under operationCommon shares41,960,00080,000,000
Ramnakara Company Limited119/129-132 Nawamin Road, Nawamin Sub-district, Bueng Kum District, Bangkok 10240Bangkok10240-Private HospitalCommon shares26,879,78545,000,000
Vibharam Hospital Company Limited2677 Phatthanakan Road, Suan Luang Sub-district / District, Bangkok 10250Bangkok10250-Private HospitalCommon shares100,000,000200,000,000
R Plus Asset Company LimitedPhetchaburi Road, BangkokBangkok-Private Hospital under constructionCommon shares15,624,99931,250,000
M.I. Calibration System Company Limited94 Soi Ramkhamhaeng 32 (Wiset Suk), Huamark Subdistrict, Bangkapi District, BangkokBangkok-Sales of Medical DevicesCommon shares2,199,9992,200,000
Mahasarakham Ram Hospital Company Limited118 Nakhon Sawan Road, Talat Sub-district, Mueang Maha Sarakham District, Maha Sarakham ProvinceMahasarakam-Private Hospital under constructionCommon shares1,200,0002,006,260
Vacharasirivet Company Limited123 Moo 26, Phahonyothin Road, Rob Wiang Subdistrict, Mueang Chiang Rai District, Chiang Rai 57000Chiang Rai57000-Private HospitalCommon shares2,886,5007,170,000
Legacy Golf (Thailand) Company Limited18 Moo 7, Liap Khlong Song Road, Sam Wa Tawan Ok Subdistrict, Khlong Sam Wa District, Bangkok 10510Bangkok10510-Golf CourseCommon shares105,000,000210,000,000
Phayao Ram Hospital Company Limited660 Moo 3, Tha Wang Thong Sub-district, Mueang District, Phayao Province 56000Phayao56000-Private HospitalCommon shares6,300,00015,750,000
Thonburi Rangsit Hospital Company Limited61/160 Rama 9 Road, Huai Khwang Sub-district, Huai Khwang District, Bangkok 10310Bangkok10310-Private HospitalCommon shares3,99910,000
Buriram Ruamphat Co., Ltd. (Buriram-Ram Hospital)197 Moo 2, Buriram-Phutthaisong Road, Chum Het Sub-district, Mueang District, Buriram Province 31000Buriram31000-Private HospitalCommon shares3,067,4058,500,000
Piyasiri Company Limited (Sukhumvit Hospital)316/32 Soi Sukhumvit 22, Sukhumvit Road, Khlong Toei District, Bangkok 10110Bangkok10110-Private HospitalCommon shares602,6241,760,000
Rangsiphan Company Limited170-172/1 (2nd, 3rd Floor) Boriphat Road, Ban Bat Subdistrict, Pom Prap Sattru Phai District, Bangkok 10100Bangkok10100-Sales and Repair of Medical DevicesCommon shares3,00010,000
Synphaet Nakhon Pathom Company Limited1298 Phetkasem Road, Lam Phaya Subdistrict, Mueang Nakhon Pathom District, Nakhon Pathom 73000Nakorn Phathom73000-Private HospitalCommon shares30,000,001100,000,000
Synphaet Company Limited9/99 Ramintra Road, Km. 8.5, Khwaeng/Khet Kannayao, BangkokBangkok-Private HospitalCommon shares32,948,889116,000,000
Renal Serve Company Limited719 KBM Building, Unit D1, 19th Floor, Rama IX Road, Bang Kapi Subdistrict, Huai Khwang District, Bangkok 10310Bangkok10310-Medical devices and suppliesCommon shares570,0003,000,000
Buranawej Company Limited (Phetcharat Hospital)2/1 Samakkhi Thai Road, Nai Mueang Sub-district, Mueang District, Phetchabun Province 67000Phetchabun67000-Private HospitalCommon shares1,342,1277,500,000
Khon Kaen Ram Hospital Company Limited193 Srichan Road, Mueang District, Khon Kaen Province 40000Khon Kaen40000-Private HospitalCommon shares1,312,2008,000,000
Synphaet Serirak Company Limited44 Seri Thai Road, Min Buri Sub-district, Min Buri District, Bangkok 10510Bangkok10510-Private HospitalCommon shares2,000,00012,200,000
Poompanya International Co., Ltd.50 Huay Kaew Road, Chang Phueak Subdistrict, Mueang Chiang Mai District, Chiang Mai 50300Chiang Mai50300-Educational InstitutionCommon shares980,0006,000,000
Viphawadi Hospital Public Company Limited51/3 Ngamwongwan Road, Lat Yao Sub-district, Chatuchak District, Bangkok 10900Bangkok10900-Private HospitalCommon shares1,526,648,33313,576,011,474
Sahaphat Phesat Company Limited450 Soi Rama 2 Soi 50, Samae Dam Sub-district, Bang Khun Thian District, Bangkok 10150Bangkok10150-Dispensing MedicineCommon shares430,0004,286,000
Synphaet Pattanakarn Company Limited508 Ramintra Road, Ramintra Subdistrict, Kannayao District, Bangkok 10230Bangkok10230-Private HospitalCommon shares5,000,00050,000,000
Chiangmai Ram Hospital Company Limited8 Boonruangrit Road, Si Phum Subdistrict, Mueang DistrictChiang Mai50200052004699Private HospitalCommon shares17,156,66740,000,000
Thonburi Healthcare Group Public Company Limited34/1 Itsaraphap Road, Ban Chang Lo, Bangkok NoiBangkok10700024872000Private HospitalCommon shares1,789,154,3601,789,154,360

Shareholders with Potential Conflict of Interest

Has Potential-Conflict Shareholder (Y/N)

Yes

Relationships Among Major Shareholders

Relationship Exists (Y/N)

No

Shareholders' Agreement

Agreement Exists (Y/N)

No

Shareholding Diagram (Group Structure)

Does the company hold shares in other companies?

Yes

Subsidiaries

Company NameJuristic Persons / Holders
Chaiyapum Ram Hospital Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 78.34 · Shareholding proportion percent: 78.34
Muang Loei-Ram Hospital Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 77.67 · Shareholding proportion percent: 77.67
Vientiane Ram International Hospital Co., Ltd. (Vientiane Ram International Hospital)RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 70.0 · Shareholding proportion percent: 70.0
Nan-Ram Hospital Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 52.45 · Shareholding proportion percent: 52.45
Ram Nakara Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 59.73 · Shareholding proportion percent: 59.73
Vibharam Hospital Co., LtdRAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 50.0 · Shareholding proportion percent: 50.0
R-Plus Asset Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 50.0 · Shareholding proportion percent: 50.0
M.I.Calibation System Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 100.0 · Shareholding proportion percent: 100.0
Mahasarakham Ram Hospital Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 59.81 · Shareholding proportion percent: 59.81
Watcharasirivej Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 40.26 · Shareholding proportion percent: 40.26
Chiangmai Ram HospitalRAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 50.01 · Shareholding proportion percent: 50.01
Thonburi Healthcare Group Public Company LimitedRAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 49.99 · Shareholding proportion percent: 49.99

Associated Companies

Company NameJuristic Persons / Holders
Legacy Golf (Thailand) Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 50.0 · Shareholding proportion percent: 50.0
Phayao Ram Hospital Co., LtdRAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 40.0 · Shareholding proportion percent: 40.0
Thonburi Rangsit Hospital Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 25.0 · Shareholding proportion percent: 25.0
Buriram Ruampaet Co., Ltd. (Buriram Ram Hospital)RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 36.09 · Shareholding proportion percent: 36.09
Piyasiri Co., Ltd. (Sukhumvit Hospital)RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 34.24 · Shareholding proportion percent: 34.24
Radio Logical Equipment Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 30.0 · Shareholding proportion percent: 30.0
Synphaet Nakhon Pathom Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 30.0 · Shareholding proportion percent: 30.0
Synphaet Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 28.4 · Shareholding proportion percent: 28.4
Renal Serve Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 19.0 · Shareholding proportion percent: 19.0
Buranavetch Co., Ltd. (Phetcharat Hospital)RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 17.9 · Shareholding proportion percent: 17.9
Khonkaen Ram Hospital Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 16.4 · Shareholding proportion percent: 16.4
Synphaet Seriruk Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 16.39 · Shareholding proportion percent: 16.39
Bhumpanya International Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 16.33 · Shareholding proportion percent: 16.33
Vibhavadi Medical Center Pcl.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 11.25 · Shareholding proportion percent: 11.25
The Medic Pharma Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 10.03 · Shareholding proportion percent: 10.03
Synphaet Phatthanakan Co., Ltd.RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED · Voting rights percent: 10.0 · Shareholding proportion percent: 10.0

Income Structure

Product / Service Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenue from operationsTotal revenue from operations14,771,619.041009,867,598.31009,634,130.28100
Medical Treatment Revenue13,339,427.8290.38,965,308.9490.868,542,323.1888.67
Revenue from sales of medical devices and medical supplies1,135,798.587.69902,289.369.141,091,807.0811.33
Revenue from Services (Medical and Other Services)278,880.521.890000
OtherOthers17,512.120.120000

Export Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenueTotal revenue14,771,619.041009,867,598.31009,634,130.28100
DomesticDomestic14,771,619.041009,867,598.31009,634,130.28100
InternationalInternational000000

Other Income

Operating Other IncomeNon-Operating Other IncomeShare of Profit
1710 · As of year: 2022546.68 · Description: Total other income · As of yesteryear: 361088.24 · As of year before yesteryear: 699604.94 · 1711 · As of year: 0.0 · Description: Other income from operations · As of yesteryear: 0.0 · As of year before yesteryear: 0.01712 · As of year: 2022546.68 · Description: Other income not from operations · As of yesteryear: 361088.24 · As of year before yesteryear: 699604.941713 · As of year: 673993.0 · Description: Share of profit · As of yesteryear: 56809.44 · As of year before yesteryear: 707724.44

Product / Service Characteristics

Business Type

3114

Business Groups

Business GroupDescription
(1) Business of operating a medical facility
  1. Hospital Business Operations

Ramkhamhaeng Hospital Public Company Limited Group operates private hospitals, providing comprehensive medical services by specialist physicians in all fields, experienced personnel, and modern medical equipment to general patients and patients under government health welfare schemes, such as patients under the Social Security Scheme (SSO) and patients under the National Health Security Office (NHSO) schemes, for both outpatients and inpatients. The total registered bed capacity is over 8,301, with 8,101 beds in Thailand and 200 beds abroad.

1.1) Domestic Healthcare Business

Private hospitals in Bangkok and its vicinity, totaling 10 hospitals

Ramkhamhaeng Hospital Group

  • Ramkhamhaeng Hospital

  • Ramkhamhaeng Hospital 2

Viphaporn Hospital Group

  • Viphaporn Hospital

  • Viphaporn Hospital - Pak Kret

  • Viphaporn Hospital Samut Prakan

  • Panya Medical Hospital

Thonburi Hospital Group

  • Thonburi Hospital

  • Thonburi Thawi Watthana Hospital (formerly "Thonburi Hospital 2")

  • Thonburi Bamrungmuang Hospital

  • Thonburi Burana Hospital, Pathum Thani Province

Private hospitals in other provinces, totaling 12 hospitals

Ramkhamhaeng Hospital Group

  • Muang Loei Ram Hospital

  • Chiangrai Ram Hospital

  • Chaiyaphum-Ram Hospital

Viphaporn Hospital Group

  • Viphaporn Hospital (Amata Nakorn)

  • Viphaporn Hospital – Laem Chabang Branch

  • Viphaporn Hospital Samut Sakhon Branch

Thonburi Hospital Group

  • Thonburi Rat Yindee Hospital, Songkhla Province

  • Thonburi Thung Song Hospital, Nakhon Si Thammarat Province

  • Thonburi Trang Hospital, Trang Province

Chiangmai Ram Hospital Group

  • Chiangmai Ram Hospital

  • Theppanya Hospital

  • Theppanya Hospital 2

1.2) International Healthcare Business

This business, under the THG Group, has partnered with local ally Ga Mone Pwint Company Limited ("GMP"), a renowned retail and real estate developer in Myanmar, to establish a joint venture for operating an international standard hospital in Myanmar named Ar Yu International Hospital. It began providing services initially for outpatients in September 2018 and fully opened on March 17, 2019. Currently, it has 200 beds and 37 examination rooms and has received JCI (Joint Commission International) accreditation.

1.3) Medical Service Outsourcing Business

THG has gained the trust of local administrative organizations to manage hospitals for public hospitals seeking to enhance management efficiency. The Company has entered into a service contract to manage and operate one hospital under a local administrative organization, namely a Sub-district Health Promoting Hospital (Tambon Health Promoting Hospital) in Phuket Province.

1.4) Specialized Medical Center Business

THG recognized the growth potential of the specialized medical center business and thus established Thonburi Sermrat Company Limited (formerly Thonburi Hospital Heart Center Company Limited). This company operates by contracting to manage heart centers for both public and private healthcare facilities, providing renowned specialist cardiologists for comprehensive care. It has undertaken three heart disease medical service outsourcing projects, namely:

  • Thonburi Thawi Watthana Hospital Heart Center Clinic (formerly "Thonburi Hospital 2")

  • Heart Center Clinic, Phatthalung Hospital

Thonburi Sermrat Company Limited commenced operations on April 17, 2018, and received approval from the National Health Security Office to treat patients under the universal healthcare scheme on October 1, 2018.

  • Cardiovascular Center, Panyananthaphikkhu Chonprathan Medical Center

Thonburi Sermrat Company Limited signed an academic cooperation agreement to manage the Heart Center for Panyananthaphikkhu Chonprathan Medical Center (formerly Chonprathan Hospital) under Srinakharinwirot University. This cooperation agreement expired in March 2025. The company is currently awaiting the results of the bidding process to renew the service contract. The objective is to ensure that the Heart Center, with its team of specialized expert physicians, can continue to provide services in conjunction with Panyananthaphikkhu Chonprathan Medical Center or as part of public services continuously and with maximum efficiency.

Specialized Medical Centers (Ramkhamhaeng Hospital and its network hospitals)

Currently, the Group has established a Centre of Excellence at Ramkhamhaeng Hospital and operates specialized medical centers to provide comprehensive medical services to outpatients and inpatients 24 hours a day, comprising:

1

Eye Clinic

14

Physical Therapy Department

2

Ear, Nose, and Throat Clinic

15

Oncology Department

3

Gastrointestinal System Clinic

16

Psychiatry Department

4

Obstetrics-Gynecology Clinic

17

Respiratory Disease Department

5

Pediatric Clinic

18

Orthopedic Center

6

Dermatology Clinic

19

Health Screening and Occupational Health Department

7

Health and Weight Loss Center

20

Health Check-up Center

8

Dental Clinic

21

Patient Rooms

9

Internal Medicine Clinic

22

Critical Care Patient Rooms

10

Gastrointestinal and Liver Clinic

23

Radiology and Lab Center

11

Diabetes Clinic

24

Emergency Room

12

General Surgery Department

25

Pharmacy Department

13

Nephrology Department

The Company has integrated digital technology into its healthcare services, enhancing the accuracy and speed of diagnosis and treatment. This enables the delivery of new medical services that align with contemporary lifestyles, ensuring high-quality medical care and a positive experience for all service users. Ramkhamhaeng Hospital has developed an electronic patient information management system (Hospital Information System) and various applications to facilitate fast, accurate, and safe patient care. This also allows patients and service users to access their treatment information, view details of hospital services, receive self-care knowledge, and important medication details, as well as schedule appointments with doctors and conveniently purchase medical equipment and hospital medical services. The aim is for Ramkhamhaeng Hospital to truly be a smart hospital for all patients.

Furthermore, the Company has developed a system to connect healthcare databases among network hospitals that share a common system. This facilitates convenience when patients seek treatment at different hospitals, allowing doctors to access useful medical history information for care, while prioritizing the highest level of data security and patient privacy. To cater to the lifestyle of the new generation, the Company has expanded online communication channels, including the hospital's website and social media platforms, as well as leading online forums in Thailand such as Facebook, Line, and Pantip.com. These platforms provide beneficial health information, introduce and communicate various medical services of the hospital, and serve as a channel for contacting and providing information to patients and those interested in the hospital's services. Additionally, they enhance access to online medical products and health services through the Ram Market Place online store and other online marketplaces such as Lazada, Shopee, etc.

(2) Business of selling medical devices, pharmaceuticals, and medical supplies, and providing medical device calibration services (M.I.CAL.SYSTEM)

Ramkhamhaeng Hospital Public Company Limited has a department for procuring quality medical equipment, medical supplies, and laboratory systems directly from manufacturers for use in its own hospital and its network hospitals. It can also distribute these to other hospitals, both public and private. The large volume of orders for multiple hospitals provides significant bargaining power and helps network hospitals effectively control costs for essential equipment, medical supplies, and laboratory systems.

Due to the continuous growth of the M.I.CAL.SYSTEM business, and to ensure clarity in efficient business operations, on March 13, 2023, the Company established M.I. Calibration System Company Limited as a subsidiary, with the Company holding 99.99% of its shares. This subsidiary was established to engage in the business of selling medical instruments, laboratory diagnostic supplies, and medical instrument calibration services to the Company, its affiliates, and third parties.

The business of selling medical instruments, pharmaceuticals, and medical supplies, and providing medical instrument calibration services (M.I.CAL.SYSTEM) continued to generate revenue for the company in 2025. In 2025, the Company had a total revenue of 1,424 million Baht. Sales revenue accounted for 95%, and service revenue accounted for 5%, representing an increase of 9.63% from the previous year.

(3) Pharmaceutical and Medical Supplies Sales Business

The Company has co-invested in joint ventures engaged in the sale of medical devices and supplies, with experience in manufacturing, importing, distributing pharmaceuticals, medical supplies, dialysis solutions, and providing medical device repair services, namely:

Company

Business

capital (Baht)

Shareholding

Ramkhamhaeng Hospital Public Company Limited

Rangsiphan Company Limited

Sale and repair of medical devices

10,000,000

30.00%

Renal Serve Company Limited

Sale of medical devices and supplies

30,000,000

19.00%

Sahaphat Phesat Company Limited

Pharmaceutical distribution

42,860,000

10.03%

Thonburi Hospital Group Public Company Limited

DS All Company Limited

Distribution of dental products

31,932,650

99.43%

T.H. Health Company Limited

Procurement of pharmaceuticals and medical supplies

41,000,000

51.22%

These 5 companies will sell and provide services to affiliated hospitals at special prices, lower than those offered to general hospitals.

(4) Service Business

The Company, under Thonburi Group, is the first private hospital entrusted by local administrative organizations to manage hospitals in collaboration with public hospitals seeking to enhance management efficiency. Currently, Thonburi Healthcare Group Public Company Limited and its affiliates, operating under the name Thonburi Sermrat Company Limited, have entered into service agreements to manage and operate three hospitals under local administrative organizations and sub-district health promoting hospitals, namely:

  • Phuket Provincial Administrative Organization Hospital, with 129 registered beds, aims to be a hospital for the public, providing excellent national-level quality services and creating a lasting impression on every service recipient. With qualified medical professionals and personnel, comprehensive management capabilities across all hospital departments, and the ability to provide efficient and high-quality services, patients receive private-sector level care at public hospital prices. The hospital has a team of doctors and nurses caring for patients 24 hours a day.

  • Phuket Provincial Administrative Organization Sub-district Health Promoting Hospital (Phuket PAO SHPH) covers 21 Sub-district Health Promoting Hospitals in Phuket Province, with the objective of providing comprehensive, continuous, and holistic healthcare to the public and communities within its responsible areas, across all age groups, including the sick, at-risk, and vulnerable populations.

  • Mae Hong Son Provincial Administrative Organization Sub-district Health Promoting Hospital (Mae Hong Son PAO SHPH) covers 6 Sub-district Health Promoting Hospitals in Mae Hong Son Province. Operations commenced in May 2025, providing telemedicine services to elevate healthcare services in remote areas. Specialist doctors and family medicine physicians conduct examinations and provide consultations online. This marks another significant step in complementing government efforts to expand equitable access to healthcare services for the public, regardless of their location in the country.

(5) Investment in Associate Companies and Subsidiaries

In addition to the hospital business and the sale of medical devices, pharmaceuticals, and medical supplies, the Company identifies opportunities to invest in associates and other companies, including hospital businesses, hospital-related businesses, and other ventures. The Company consistently receives annual dividend returns from the performance of these invested companies. As of December 31, 2025, the Company's dividend income amounted to 258.15 million Baht.

Research & Development

Has R&D Policy (Y/N)

No

R&D Cost — Description

-

R&D Cost — Label

Research and development (R&D) expenses over the past 3 years (Million Baht)

R&D Cost — This Year

0.0

R&D Cost — Last Year

0.0

R&D Cost — 2 Years Ago

0.0

Assets Used in the Business

Permanent Assets — Description

Assets used in the business operations of the Company and its subsidiaries, intended for normal business operations of the organization as of December 31, 2025.

  1. Key fixed assets

Assets

Nature of ownership

Ramkhamhaeng PCL
(Million Baht)

Subsidiary
(Million Baht)

Total
(Million Baht)

Land

Owned

836

9,344

10,180

Land improvement

Owned

6

55

61

Buildings and improvements

Owned

343

8,998

9,341

Building and improvement

Owned

-

2,633

2,633

Medical equipment

Owned

263

2,444

2,707

Office equipment

Owned

24

357

381

Furniture and fittings

Owned

6

754

760

General equipment

Owned

16

2

18

Vehicles

Owned

17

111

128

Owned

127

4,492

4,619

Total land, buildings, and equipment - net

1,638

29,190

30,828

Note: -

  1. Right-of-use assets

Right-of-use assets

Type of ownership

Ramkhamhaeng PCL
(Million Baht)

Subsidiary
(Million Baht)

Total
(Million Baht)

Land

Right to use under contractual terms

-

1,794

1,794

Buildings

Right to use under contractual terms

-

34

34

Medical equipment

Right to use under contractual terms

-

3

3

Furniture and fixtures

Right to use under contractual terms

-

8

8

Computer equipment

Right to use under contractual terms

-

3

3

Vehicles

Right to use under contractual terms

-

6

6

Total right-of-use assets

-

1,847

1,847

Significant land use rights are subject to the following conditions:

  1. On July 22, 2021, the Company and the joint venture entered into an agreement to obtain lease rights with Rajamangala University of Technology Krungthep. The Company paid land lease rights totaling 52 million Baht, and the joint venture has the right to construct buildings on the leased area. Upon termination of the agreement, it was agreed to transfer ownership of all buildings and their appurtenances to Rajamangala University of Technology Krungthep. The agreement stipulates a construction and land development period of 3 years, from January 20, 2022, to January 19, 2025, with no rent payable. Upon completion, the joint venture will enter into a land lease agreement for a period not exceeding 30 years, with an annual rent of 3.2 million Baht and a 10% rent increase every 5 years.

On September 18, 2023, the Company and its subsidiary no longer wished to co-invest in the joint venture. Therefore, a memorandum of understanding was executed to transfer the right to enter into a lease agreement with Rajamangala University of Technology Krungthep to the co-venturer, and the co-venturer was appointed to find new investors to join the project. Consequently, the Company recorded a gain from the termination of the lease agreement amounting to 12.43 million Baht in the statement of comprehensive income. Regarding the 52 million Baht that the Company had paid to Rajamangala University of Technology Krungthep, the co-venturer agreed to repay this amount to the Company, and it has been presented under other non-current assets in the statement of financial position.

On November 14, 2024, Rajamangala University of Technology Krungthep sent a letter of contract termination to the joint venture, stating that from the date of signing the contract until now, which marks the completion of the 3-year period, the joint venture has not carried out any construction in accordance with the contract. Although the joint venture has sent several letters of clarification and dispute, Rajamangala University of Technology Krungthep insists on terminating the contract with the joint venture. Currently, the joint venture has filed a lawsuit against Rajamangala University of Technology Krungthep to reclaim the land lease rights fee of 52 million Baht. The Company has already recorded an expected credit loss allowance of 52 million Baht in its financial statements.

  1. On June 1, 2020, a subsidiary entered into a land lease agreement for 13,749 square meters in Vientiane, Laos, for a period of 30 years, from June 1, 2020, to May 31, 2050, with an option to renew. The company's management considers the right-of-use land to be amortized over a period of 60 years. Additionally, the company is required to pay an annual rent of USD 100,000.

Intangible Assets — Description

  1. Intangible assets

Assets

Ownership type

Ramkhamhaeng PCL
(Million Baht)

Subsidiary
(Million Baht)

Total
(Million Baht)

Computer software

Owned

259

280

Computer software under installation

Owned

-

15

15

Customer relationships

Owned

-

42

42

Less Allowance for impairment

-

(7)

(7)

Total intangible assets

309

330

Has Subsidiaries Investment Policy (Y/N)

Yes

Subsidiaries Investment Policy — Description

The Company has a policy to invest in subsidiaries and associates operating in the private hospital business, considering that such companies are likely to achieve favorable performance in the future, with the expectation of returns in the form of dividends. The Company tends to invest in available-for-sale securities that provide an average dividend yield exceeding the market interest rate.

Marketing Policy & Competition

Reporting Mode

3117

Marketing Policy (Overall)

Hospitals operated by joint ventures and subsidiaries

Hospitals within the network of joint ventures and subsidiaries systematically coordinate patient referrals (Referral System). Patients can be referred to network hospitals for continued treatment in cases where complex medical conditions require care beyond the originating hospital's capacity, or for continuous care during recovery. This is to facilitate and enhance the quality of services provided to patients.

In addition, the aforementioned referral system also contributes to supporting the efficient utilization of resources within the network and strengthens the overall hospital network. Furthermore, the company also generates income in the form of dividends from investments in joint ventures and subsidiaries.

Industry & Competition (Overall)

Industry Overview and Competition

In 2025, the private hospital business in Thailand is projected to maintain continuous growth, with the opening of additional new private hospitals, particularly in major urban areas and tourist destinations experiencing continuous economic expansion.

Thailand is fully transitioning into an aging society. Coupled with the rising average life expectancy of the population, this significantly increases the demand for treatment of chronic and complex diseases. This trend supports the growth of hospitals within the social security system.

In the long term, the competitive landscape of the private hospital business will shift towards network-based competition. Hospital groups with networks and medical partnerships will gain an advantage through patient referrals, shared resource utilization, and the transfer of medical knowledge, as well as efficient cost management.

Concurrently, digital technology continues to play a crucial role (digital disruption). Hospitals that invest in developing digital systems, including internal operating systems, patient data management, and service connectivity from pre-treatment, during treatment, and post-treatment, as well as Telemedicine services, will be able to enhance patient access, create opportunities for revenue expansion, and effectively strengthen their adaptability to changing situations.

Procurement of Products & Services

Reporting Mode

3117

Procurement (Overall)

  1. Medical personnel

Physicians are a crucial factor for the hospital business. Ramkhamhaeng Hospital and its network hospitals have sufficient specialized physicians to provide services in each treatment department, while nurses and other medical personnel possess extensive experience in patient care. The recruitment and selection of medical personnel are conducted under the consideration of the Medical Director and rely on a referral system to ensure experienced and qualified personnel. Furthermore, Ramkhamhaeng Hospital and its network hospitals have a long-standing reputation and credibility, which continuously attracts medical personnel interested in employment.

  1. Medicines and medical supplies

Most procurement of medicines and medical supplies is conducted through local market suppliers, as these are generally available products with numerous suppliers. However, for certain types of treatments, hospitals also need to procure additional medicines and medical supplies from abroad. Currently, despite the presence of major suppliers in the market, there is no monopoly by any single supplier. This allows the hospital group to select quality suppliers and manage costs efficiently. Furthermore, the hospital group prioritizes quality control, safety standards, and continuity of supply to effectively support medical services.

  1. Medical equipment and instruments

The Company has established a dedicated business unit to oversee the procurement of medical equipment and instruments, as well as maintenance. This is carried out both through internal departments and directly through distributors or medical device manufacturers.

The Company selects modern medical tools and equipment, sourcing them from abroad, such as China, Korea, Germany, and the United States, or through distributors in Thailand, to ensure the quality and standards of medical care. This business unit not only supports the needs of the Company and its subsidiaries but also provides procurement services to partner hospitals within the network. This enables the Company to plan procurement in advance, increase bargaining power with suppliers, and achieve cost efficiency, coupled with receiving quality after-sales services, thereby enhancing the overall resource management efficiency of the group.

Raw Material Acquisition (Overall)

  1. Medical Service Pricing

The Company's medical service pricing is primarily determined by customer groups, which can be divided into two main categories as follows:

  1. General Customer Group

This includes self-paying customers, contractual customers, and customers utilizing health insurance benefits. Pricing is primarily based on physician fees, service costs, medical supplies, and related medical equipment. Furthermore, the Company considers the complexity of the treatment and the appropriateness of pricing for service recipients in each area.

Additionally, for certain services with relatively fixed costs, the Company offers package pricing (e.g., childbirth and annual health check-ups) to facilitate easier and faster decision-making for service recipients.

  1. Customer groups under social security and universal healthcare schemes

Medical service fees for this group are in accordance with rates stipulated by government agencies, namely the Social Security Office and the National Health Security Office, with the following primary payment models:

  1. Capitation service fees (payment for services based on the number of eligible individuals registered with the hospital

  2. Non-capitation fees include services for high-risk diseases (e.g., outpatient services for certain chronic diseases) and inpatient services for high-cost diseases, which are determined by the relative weight of the treatment (

These service fees will be based on actual services rendered, within the budget and conditions stipulated by the relevant agencies.

Production Policy (Overall)

As of December 31, 2025, the hospitals under the Company and its subsidiaries have a registered capacity of 3,626 beds, ready to serve general patients and patients under government health welfare schemes. As of December 31, 2025, Vibharam Hospital Group has an average of 490,749 insured persons under the social security scheme.

The full production capacity details of the Company and its subsidiaries are divided into 4 main groups, as follows:

Production Capacity (Overall)

ItemUnitUnit (if Other)UsedCapacity
Ramkhamhaeng HospitalOthersBed43.781,709

Domestic/Overseas Purchase Proportion (Overall)

Raw MaterialSource CountryValue
Medicines and Medical SuppliesThailand479,726.61

Projects Under Construction

Has Projects Under Construction (Y/N)

No

Debentures & Bills of Exchange

Has Debentures (Y/N)

No

Convertible Securities

Has Convertible Securities (Y/N)

No

Contents